Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
respiratory diseases
Research
GSK and Cambridge scientists join forces in $65M immune R&D deal
The partners will focus on mechanisms of disease onset, disease progression, patient response to therapies and developing translational biomarkers.
Darren Incorvaia
Oct 22, 2024 3:30pm
Nasal spray protects mice from deadly flu
Oct 2, 2024 8:54am
GSK's long-acting asthma drug halved attacks in phase 3
Sep 9, 2024 9:30am
GSK's SWIFT trials show long-acting treatment reduces attacks
May 21, 2024 2:00am
Surrozen's Wnt mimetic antibody works in mice with lung fibrosis
Apr 4, 2024 4:30am
Clario buys AI firm ArtiQ, taps CEO to head AI strategy
Apr 3, 2024 4:00pm
